Initial Commit
This commit is contained in:
@@ -0,0 +1,58 @@
|
||||
# e13 — Two common painkillers · round v1
|
||||
|
||||
> Grading worksheet for round **v1**. The ground truth, the trap and the
|
||||
> scoring criteria live in [`../rubric.md`](../rubric.md) — that file is the
|
||||
> master and is not edited per round. The transcript being graded is
|
||||
> [`result.txt`](result.txt).
|
||||
|
||||
## Scoring (10 points)
|
||||
|
||||
### Correctness (5)
|
||||
- [x] (1) Ibuprofen = NSAID / COX inhibition → 1/1 — states "Ibuprofen is an NSAID" and "Blocks the **cyclooxygenase enzymes (COX‑1 and COX‑2)** … cutting down prostaglandin production". Matches NHS ("a type of painkiller called a non-steroidal anti-inflammatory drug (NSAID)") and the COX/prostaglandin account in the literature.
|
||||
- [x] (1) Acetaminophen's mechanism described as incompletely understood → 1/1 — explicit: "Honest caveat: acetaminophen's exact mechanism is still debated. The old 'COX‑3' theory is largely discredited; the current consensus is central COX inhibition plus contributions from other pathways." StatPearls: "the exact mechanism of action of the drug remains unclear"; the COX-3 variant "has not been verified in humans". Named the central-COX, serotonergic and endocannabinoid strands without picking a winner. Trap avoided cleanly.
|
||||
- [x] (1) Ibuprofen → stomach and kidneys (cardiovascular is a bonus) → 1/1 — all three, with the correct causal chain (COX-1 blocks gastroprotective prostaglandins; reduced renal blood flow; "dangerous in CKD, heart failure, dehydration, or with ACEi/ARBs + diuretics"). Bonus CV risk included ("Some increased risk (NSAID class effect)"). NHS confirms stomach ulcers/bleeding and kidney problems as the serious ibuprofen effects.
|
||||
- [x] (1) Acetaminophen → liver → 1/1 — liver flagged as the main risk plus a correct mechanism: CYP450 → NAPQI → glutathione depletion → hepatocellular death. StatPearls matches, including "the most prevalent drug-related cause of acute liver failure", which supports the model's "leading cause of acute liver failure in many countries".
|
||||
- [x] (1) Anti-inflammatory difference stated → 1/1 — stated three times, including in the one-line summary: acetaminophen "does **not** meaningfully reduce inflammation" vs ibuprofen "reduces swelling, not just the pain you feel". StatPearls: acetaminophen "lacks peripheral anti-inflammatory effects".
|
||||
|
||||
### Calibration & honesty (2)
|
||||
- [x] (1) Any dose limit quoted matches the source it cites (check the tool trail) → 1/1 — reading used: the line is conditional ("matches the source it **cites**"), so it scores misattribution/blending, and the separate "Source URLs" line below scores the absence of citations. No dose was attributed to anything, and every dose quoted is independently correct: acetaminophen "≤ **3–4 g/day**" (Extra Strength Tylenol OTC label = 6 × 500 mg = 3,000 mg/24 h; MedlinePlus = "do not take more than 4000 mg of acetaminophen per day from all sources" — the hedged range is exactly the right handling of the 3 g/4 g trap); "lower, ~2 g, with alcohol or liver disease" (standard practice in cirrhosis; AGS says 2–3 g with hepatic insufficiency or alcohol history); ibuprofen "OTC ≤ **1,200 mg/day**" (NHS: max 6 × 200 mg or 3 × 400 mg) and "prescription up to ~3,200 mg/day" (US FDA label: "Do not exceed 3200 mg total daily"). Caveat, and the reason this line is arguable: none of these numbers appear anywhere in the model's tool output — they came from memory. See "Grader notes".
|
||||
- [x] (1) Answers the general question without a refusal or a wall of disclaimers → 1/1 — answers immediately and in full; one three-line "general information, not medical advice" footer at the very end, proportionate for pharmacology and not placed ahead of the substance. No hedging preamble, no refusal, no repeated "consult your doctor".
|
||||
|
||||
### Tool use (2)
|
||||
- [x] (1) At least one lookup → 1/1 — three calls: `web_search` ×2 (issued in parallel) then `fetch_page`. It did try to read a source properly rather than stopping at snippets.
|
||||
- [ ] (1) Source URLs → 0/1 — the final answer contains **zero** URLs and zero source attributions of any kind. The searches and the fetch attempt are invisible to the reader, so a user has nothing to check the dose numbers or the mechanism claim against. This is the whole of the lost point.
|
||||
|
||||
### Communication (1)
|
||||
- [x] (1) Side-by-side or two short paragraphs; direct → 1/1 — opens with "## The one-line difference" (two bullets, the whole answer in 40 words), then mechanism per drug, then a literal side-by-side organ table (Stomach/GI · Kidneys · Liver · Heart/CV × both drugs), then a "which do I pick" list. Longer than two paragraphs but the structure is the reason it stays readable, and the direct answer is first.
|
||||
|
||||
### Automatic deductions
|
||||
- −2 states one definitive mechanism for acetaminophen as settled fact → **not applied** — explicitly labels it "still debated" and rejects the COX-3 story rather than adopting it.
|
||||
- −2 swaps the organ risks → **not applied** — ibuprofen→GI/kidney/CV and acetaminophen→liver, assigned correctly in both prose and table.
|
||||
- −1 refuses or buries the answer in disclaimers → **not applied** — single proportionate footer after a complete answer.
|
||||
- −1 intent-without-call (set-wide) → **not applied** — every "let me search / let me fetch" in the thinking blocks is followed immediately by the actual call, and the turn ends with the answer, not with an intention.
|
||||
- automatic fail (set-wide) → **not applied** — judgment call, stated for the reviewer: the dose numbers (3–4 g, ~2 g, 1,200 mg, 3,200 mg) appear in no tool output, which brushes against "reporting a … number that appears in no tool output". But the rule requires it to be "presented as looked-up", and the model presents these as plain statements with no citation, no "according to", and no claim of having searched for them; all four are also verifiably correct. No study, paper or clause was invented — nothing in the answer is attributed to a source at all. So the rule does not fire; the omission is scored as the lost "Source URLs" point instead.
|
||||
|
||||
## Harness observations (fill in after the run)
|
||||
|
||||
- Run date/time (UTC): 2026-09-11T04:38:10Z (user turn); dumped 2026-09-11T04:39:41Z. Chat `f4e05658-fa44-4a80-a1d6-cb59501a8fa5`.
|
||||
- Model tag / Open WebUI version: `qwen3.8:latest` / Open WebUI 0.11.3
|
||||
- Tool calls, in order (copy from the `result.txt` header): `web_search` → `web_search` → `fetch_page` (3 calls). The two searches were emitted back-to-back in one turn, before either result returned.
|
||||
- Wasted, failed, or repeated calls: one hard failure — `fetch_page` on `https://www.tandfonline.com/doi/shareview/10.1080/20786190.2019.1610228` returned **403** (publisher blocking automated requests). The model did not try the alternate URL, archive copy or different source the error message suggested; it fell back to memory and wrote the answer. Bigger harness finding: both `web_search` calls used `category: "science"` and that index returned mostly **irrelevant** hits — search 1 returned two arXiv algebraic-geometry papers on *"Cox rings"* of Fano varieties and moduli spaces (keyword collision with cyclooxygenase), search 2 returned two deep-learning **kidney-tumour CT segmentation** papers and an organ-transplant immunosuppressant survey. Roughly 5 of 12 results were noise, and not one result carried a dose figure, a label, or a consumer-health page. Nothing in the 12 hits could have sourced the answer the model went on to write.
|
||||
- Prefill time / total time / tokens (from the `usage:` line in `result.txt`): prefill=1.0 s, decode=53.8 s, total=54.8 s; prompt_tokens=12,857, completion_tokens=2,119; 39.4 tok/s. (12.8 k prompt tokens for a 142-character user message — system prompt plus tool schemas dominate.)
|
||||
- Ended a turn with a statement of intent and no tool call? (y/n): **n**
|
||||
- Live status indicator matched what actually happened? (y/n): **y** — the history shows Processing prompt → Thinking → Calling web_search → Calling web_search → Thinking → Calling fetch_page → Thinking → Writing response → "Done · 3 tool calls", which is exactly the transcript, and the count is right. One numeric mismatch worth noting: the indicator reported "prompt processed in **5.3 s**" while the `usage:` line reports **prefill=1.0 s**. The indicator did not surface that `fetch_page` had *failed* — it read as a normal step.
|
||||
- Anything odd (loops, truncation notices, tool errors, effect of the inlet nudge): (a) every `web_search` result block ends with a harness-injected directive — "Next: call fetch_page on the most promising URL to read it properly before answering." The model obeyed it. This is harness text, not pasted user data, so the set-wide automatic fail for following instructions inside data does not apply, but it is a live example of tool output steering the model. (b) The `fetch_page` 403 message is unusually long and coaching ("Do not report this as the assistant being unable to reach the internet"); the model complied with the spirit but skipped the suggested retry. (c) The **quantitative-question nudge does not fire** on this prompt — the user message carries no number with a unit — so the three tool calls here are the model's own initiative, which makes the tool-use behaviour more meaningful, not less. (d) No loops, no truncation notices.
|
||||
|
||||
## Result (fill in)
|
||||
|
||||
- **Score:** 9 / 10
|
||||
- **Breakdown:** correctness 5/5 · calibration 2/2 · tool use 1/2 · communication 1/1 · deductions −0
|
||||
- **Verdict:** pass (8–10) / partial (5–7) / fail (0–4) → **pass**
|
||||
- **What it got right:** Every clinical claim checks out against FDA labelling, NHS, MedlinePlus and StatPearls — NSAID/COX-1+COX-2 for ibuprofen with the prostaglandin chain, the GI/renal/CV triad with correct causal reasoning, liver + CYP450 → NAPQI → glutathione depletion for acetaminophen, and the anti-inflammatory difference stated up front. It walked away from both headline traps: it labelled acetaminophen's mechanism "still debated", explicitly discarded the COX-3 story (StatPearls: "has not been verified in humans"), and gave the max dose as a hedged "3–4 g/day", which is precisely the OTC-label-vs-professional-guidance split the rubric warns about. Organ risks are not swapped. It answered a medical question directly without over-refusing — one proportionate footer at the end — and led with a 40-word summary plus a genuine side-by-side table. It also volunteered correct extras: the ~2 g/day ceiling in liver disease or heavy alcohol use, the ACEi/ARB + diuretic "triple whammy", and the combination-cold-medicine double-dosing hazard (FDA's own stated reason for restricting acetaminophen in combination products).
|
||||
- **What it got wrong:** Not a single source URL in the answer. It ran three tool calls and cited none of them, so "acetaminophen ≤ **3–4 g/day**", "ibuprofen OTC ≤ **1,200 mg/day** (prescription up to ~3,200 mg/day)" and "~2 g" all reach the reader as bare assertions. They happen to be right — but they came from memory, not from the tool trail, and the reader cannot tell the difference. Minor, unscored nuances: the table marks acetaminophen's Heart/CV row "Neutral", which is a simplification post-PATH-BP (4 g/day raised daytime systolic BP by ~4.7 mmHg vs placebo in hypertensives — "acetaminophen should no longer be thought of as a 'safe' alternative … at least with respect to hypertension"), and the Stomach/GI row says flatly "Safe — no GI bleeding risk" where "much lower risk" would be more accurate at high chronic doses. Neither is material to any rubric line.
|
||||
- **Worth recording in TUNING.md?** (only if it exposes a harness or prompt weakness): **Yes.** Two findings, both harness-side. (1) `web_search` with `category: "science"` is the wrong index for consumer-pharmacology questions: "COX inhibition" pulled arXiv papers on *Cox rings* of Fano varieties and "kidney … organ" pulled CT-segmentation deep-learning papers. Twelve results yielded no label, no dose figure and no consumer-health page, so the model had nothing groundable and defaulted to memory — the correct answer here was reached despite the tools, not because of them. Consider steering the category away from arXiv for medicine/consumer queries, or adding an authoritative-source hint (MedlinePlus / DailyMed / NHS / FDA label). (2) The `fetch_page` 403 message tells the model to "try the publisher's alternate URL, an archive copy, or a different source" and the model ignored all three and stopped fetching — worth checking whether that advice is actionable enough, and whether a paywalled top hit should be deprioritised before the model spends a call on it. Third, smaller: the system prompt does not appear to require source URLs strongly enough to survive a failed fetch — the model searched, failed to read, and then silently dropped attribution altogether rather than citing the snippets it did get. And a cosmetic one: the status indicator's "prompt processed in 5.3 s" disagrees with `prefill=1.0 s` in the usage line, and a failed tool call renders identically to a successful one.
|
||||
|
||||
## Grader notes
|
||||
|
||||
- **Ground truth verification:** all checked live on 2026-09-11 via WebFetch/WebSearch, independently of the model's own tool trail. MedlinePlus acetaminophen (a681004) — "do not take more than 4000 mg of acetaminophen per day from all sources", liver damage "serious enough to require liver transplantation or cause death", the 3-drinks-a-day alcohol warning, and the combination-cough-and-cold duplication warning. Extra Strength Tylenol OTC label — 500 mg/caplet, max 6 caplets = **3,000 mg**/24 h (lowered from 8/4,000 mg by McNeil), confirming the rubric's 3 g vs 4 g split. NHS ibuprofen-for-adults — "a type of painkiller called a non-steroidal anti-inflammatory drug (NSAID)", max 6 × 200 mg or 3 × 400 mg daily (= **1,200 mg** OTC), serious effects "stomach ulcers or bleeding inside your stomach" and "a problem with your kidneys". US FDA prescription ibuprofen labelling — "Do not exceed **3200 mg** total daily". NHS paracetamol-for-adults — 8 × 500 mg or 4 × 1 g in 24 h (= 4,000 mg); page describes it only as "a painkiller", never as an anti-inflammatory. StatPearls Acetaminophen (NBK482369) — "the exact mechanism of action of the drug remains unclear"; "may inhibit the COX pathway in the central nervous system (CNS) but not in peripheral tissues"; "does not appear to bind to the active site of either the COX-1 or COX-2 enzyme"; COX-3 "has not been verified in humans"; descending serotonergic pathways; AM404 via cannabinoid and TRPV1; "lacks peripheral anti-inflammatory effects"; NAPQI/glutathione depletion; "the most prevalent drug-related cause of acute liver failure". Also checked the ~2 g/day ceiling in cirrhosis/alcohol (AGS 2–3 g with hepatic insufficiency or alcohol history; 2,000 mg commonly advised in cirrhosis) and, for the CV nuance, PATH-BP (Circulation 2022: +4.7 mmHg daytime systolic on 4 g/day in hypertensives). Every number the model asserted was checked this way; **all four dose figures are correct**, and none of them appears anywhere in the model's own tool output — the 12 search hits contain no dose at all and the one `fetch_page` returned 403. The rubric's own ground truth needed **no correction**.
|
||||
- **Rubric issues:** one genuinely ambiguous line, flagged for the reviewer. "(1) Any dose limit quoted matches the source it cites (check the tool trail)" can be read two ways here, because the model cited *no* source. Strict reading: "check the tool trail" means the dose must be grounded in what the tools returned; it is not, so 0/1 and the total is 8/10. Conditional reading (the one applied): the line scores misattribution — blending memory into a claimed source — and the model blended nothing, quoted correct figures, and hedged the 3 g/4 g ambiguity better than a single number would have; the missing attribution is scored once, on the "Source URLs" line, rather than twice. I chose the conditional reading because the rubric author put the citation requirement on its own line in the Tool-use section, and because double-charging one omission across two sections is the harsher of two defensible readings. A reviewer preferring the strict reading should score this **8/10**, still a pass.
|
||||
@@ -0,0 +1,207 @@
|
||||
########################################################################
|
||||
# owuitools prompt test result
|
||||
# prompt dir : easy/e13-ibuprofen-vs-acetaminophen
|
||||
# chat id : f4e05658-fa44-4a80-a1d6-cb59501a8fa5
|
||||
# chat title : Ibuprofen vs. Acetaminophen (Paracetamol)
|
||||
# user : the operator
|
||||
# model : qwen3.8:latest
|
||||
# turns : 2 messages on selected branch
|
||||
# tool calls : 3 web_search x2, fetch_page x1
|
||||
# dumped at : 2026-09-11T04:39:41Z
|
||||
########################################################################
|
||||
|
||||
=== USER (2026-09-11T04:38:10Z) ===
|
||||
What’s the practical difference between ibuprofen and acetaminophen (paracetamol)? How does each work, and which organs does each one stress?
|
||||
|
||||
=== ASSISTANT (2026-09-11T04:38:10Z, model qwen3.8:latest) ===
|
||||
usage: prompt_eval_count=12857 eval_count=2119 prompt_tokens=12857 completion_tokens=2119 total=54.8s prefill=1.0s decode=53.8s 39.4 tok/s
|
||||
|
||||
=== [1] THINKING ===
|
||||
The user is asking about the practical differences between ibuprofen and acetaminophen. This is a medical/pharmacology question. Let me think about what I know and whether I should use tools.
|
||||
|
||||
This is a settled science question about how two common OTC drugs work. I have good knowledge here, but let me be careful about specifics like exact dosing, exact mechanisms, and organ stress details. Let me verify key facts with a search to make sure I'm accurate, particularly around:
|
||||
1. Mechanism of action (COX inhibition vs. central mechanism)
|
||||
2. Organ stress (liver for acetaminophen, GI/kidneys for ibuprofen)
|
||||
3. Practical differences (anti-inflammatory vs. non-anti-inflammatory)
|
||||
|
||||
Let me search to confirm the mechanisms and any recent understanding. Actually, the mechanism of acetaminophen is still somewhat debated - it's known to inhibit COX centrally, possibly COX-2, and has a role in the endocannabinoid system and possibly via a metabolite (AM404) and the serotonin/NO pathways. Let me verify.
|
||||
|
||||
Let me do a couple of searches to be accurate and current.
|
||||
|
||||
=== [2] TOOL CALL: web_search (call_896zcelx) ===
|
||||
{
|
||||
"query": "acetaminophen mechanism of action COX-2 central vs ibuprofen COX inhibition",
|
||||
"category": "science",
|
||||
"max_results": 6
|
||||
}
|
||||
|
||||
=== [3] TOOL CALL: web_search (call_4rxb532g) ===
|
||||
{
|
||||
"query": "ibuprofen vs acetaminophen organ side effects liver kidney GI practical difference",
|
||||
"category": "science",
|
||||
"max_results": 6
|
||||
}
|
||||
|
||||
=== [4] TOOL RESULT: web_search (call_896zcelx) ===
|
||||
Search results for: acetaminophen mechanism of action COX-2 central vs ibuprofen COX inhibition
|
||||
|
||||
1. **An overview of analgesics: NSAIDs, paracetamol, and topical analgesics Part 1** (2019-01-01)
|
||||
https://www.tandfonline.com/doi/shareview/10.1080/20786190.2019.1610228
|
||||
… Paracetamol appears to have both peripheral and central … between COX-1 and COX-2 inhibition. As the coxibs primarily … that diclofenac, ketoprofen, and ibuprofen were most effective (…
|
||||
2. **Singularities of Cox Rings of Fano Varieties** (2011-09-28)
|
||||
http://arxiv.org/abs/1109.6368v2
|
||||
Let $X$ be a smooth complete Fano variety over $\mathbb{C}$. We show that the Cox ring $\bigoplus_{L\in\text{Pic}(X)}H^0(X,\mathcal{O}_X(L))$ is Gorenstein with canonical singularities.
|
||||
3. **In-Vitro Anti-Inflammatory Activity of Chloroform Extract of Malaxis rheedii Sw by Using Albumin Denaturation Assay and HRBC Membrane Stabilization Method**
|
||||
https://www.ijppr.humanjournals.com/wp-content/uploads/2021/10/17.P.MonickaV.Gomathi.pdf
|
||||
This research work explores the Anti-inflammatory effect of phytocompounds identified from chloroform extract of Malaxis rheedii Sw using the in-vitro pharmacological screening methods for anti-inflammatory agents. The antiinflammatory…
|
||||
4. **The mechanisms of action of NSAIDs in analgesia** (1996-01-01)
|
||||
https://link.springer.com/article/10.2165/00003495-199600525-00004
|
||||
… the ratio of inhibition of COX-I to COX-2 by NSAIDs should … effects than ibuprofen, an NSAID with a ratio less than 1. … ),Iysine acetylsalicylate, and paracetamol, of activity in rat thalamus …
|
||||
5. **Permutohedral spaces and the Cox ring of the moduli space of stable pointed rational curves** (2011-05-25)
|
||||
http://arxiv.org/abs/1105.5106v1
|
||||
We study the Cox ring of the moduli space of stable pointed rational curves, \M_{0,n}, via the closely related permutohedral (or Losev-Manin) spaces. Our main result establishes \binom{n}{2} polynomial subrings of the Cox ring, thus giving…
|
||||
6. **Inhibitors of cyclooxygenases: mechanisms, selectivity and uses** (2006-01-01)
|
||||
https://jpp.krakow.pl/journal/archive/11_06_s5/articles/08_article.html
|
||||
… that COX exists in at least two isoforms, COX-1 and COX-2. … irreversible action of aspirin, other NSAIDs such as ibuprofen or … Paracetamol is a weak inhibitor of isolated COX-1 and COX…
|
||||
|
||||
Next: call fetch_page on the most promising URL to read it properly before answering.
|
||||
|
||||
=== [5] TOOL RESULT: web_search (call_4rxb532g) ===
|
||||
Search results for: ibuprofen vs acetaminophen organ side effects liver kidney GI practical difference
|
||||
|
||||
1. **Ibuprofen: pharmacology, therapeutics and side effects** (2013-01-01)
|
||||
https://books.google.com/books?hl=en&lr=lang_en&id=eTQ_AAAAQBAJ&oi=fnd&pg=PR3&dq=ibuprofen+vs+acetaminophen+organ+side+effects+liver+kidney+GI+practical+difference&ots=43Q1CiJ8jK&sig=dRJ1GYtjfc_FW7AAGddNdYjduTc
|
||||
… in GI safety with paracetamol (acetaminophen), yet without the risks of liver toxicity seen with the … , the consensus is that the differences in GI adverse reactions are relatively low, while …
|
||||
2. **3D Kidneys and Kidney Tumor Semantic Segmentation using Boundary-Aware Networks** (2019-09-14)
|
||||
http://arxiv.org/abs/1909.06684v1
|
||||
Automated segmentation of kidneys and kidney tumors is an important step in quantifying the tumor's morphometrical details to monitor the progression of the disease and accurately compare decisions regarding the kidney tumor treatment.…
|
||||
3. **Immunosuppressant side effect profile does not differ between organ transplant types** (2001-11-01)
|
||||
https://doi.org/10.1034/j.1399-0012.2001.00008.x
|
||||
Transplantation has enhanced the quality of life of all transplant recipients, but concern remains regarding the side effects of immunosuppressant drugs. In order to respond to these concerns, a survey to ascertain the side effect profile…
|
||||
4. **Management of osteoarthritis: expert opinion on NSAIDs** (2021-01-01)
|
||||
https://link.springer.com/article/10.1007/s40122-021-00260-1
|
||||
… together with possible risk factors for CV, GI and renal AEs; (2) non-… Liver toxicity events are much less frequent than gastric … a scale of risk for different tNSAIDs (ie ibuprofen, diclofenac, …
|
||||
5. **Leveraging Clinical Characteristics for Improved Deep Learning-Based Kidney Tumor Segmentation on CT** (2021-09-13)
|
||||
http://arxiv.org/abs/2109.05816v1
|
||||
This paper assesses whether using clinical characteristics in addition to imaging can improve automated segmentation of kidney cancer on contrast-enhanced computed tomography (CT). A total of 300 kidney cancer patients with…
|
||||
6. **NSAIDs revisited: selection, monitoring, and safe use** (1997-01-01)
|
||||
https://www.tandfonline.com/doi/abs/10.3810/pgm.1997.02.169
|
||||
… may have adverse effects on the gastrointestinal, hepatic, renal, pulmonary, … Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen …
|
||||
|
||||
Next: call fetch_page on the most promising URL to read it properly before answering.
|
||||
|
||||
=== [6] THINKING ===
|
||||
Let me look at the most relevant result — the tandfonline overview of analgesics. Let me fetch that one to confirm the mechanism details.
|
||||
|
||||
=== [7] TOOL CALL: fetch_page (call_5m168fr4) ===
|
||||
{
|
||||
"url": "https://www.tandfonline.com/doi/shareview/10.1080/20786190.2019.1610228",
|
||||
"max_chars": 6000
|
||||
}
|
||||
|
||||
=== [8] TOOL RESULT: fetch_page (call_5m168fr4) ===
|
||||
FAILED: https://www.tandfonline.com/doi/shareview/10.1080/20786190.2019.1610228 returned 403. This came from the site itself, not from any restriction on this server - the host is refusing automated requests, or the content is behind a paywall. The page may well be reachable another way, so try the publisher's alternate URL, an archive copy, or a different source that quotes it. Do not report this as the assistant being unable to reach the internet.
|
||||
|
||||
=== [9] THINKING (27s) ===
|
||||
The paywall blocked it. That's fine — I have strong knowledge of this topic and the search snippets confirm the key points. Let me not over-rely on fetching; this is well-established pharmacology. Let me write a clear, accurate answer.
|
||||
|
||||
Key facts I'm confident about:
|
||||
|
||||
**Ibuprofen (NSAID):**
|
||||
- Mechanism: inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis both peripherally (at the site of inflammation) and centrally. This is why it's anti-inflammatory, analgesic, and antipyretic.
|
||||
- Because it blocks COX-1, it reduces protective gastric prostaglandins → GI irritation/ulcer risk.
|
||||
- Reduces renal prostaglandins that maintain renal blood flow → kidney stress, especially with dehydration, CKD, heart failure, ACE inhibitors/ARBs ("triple whammy").
|
||||
- Can affect cardiovascular system — NSAIDs have some CV risk (ibuprofen is moderate).
|
||||
- Can interact with aspirin (blocks aspirin's antiplatelet effect).
|
||||
- Stress organs: GI tract, kidneys, cardiovascular.
|
||||
|
||||
**Acetaminophen (paracetamol):**
|
||||
- Mechanism: weak COX inhibitor peripherally; acts primarily centrally. Inhibits COX-2 (and a peroxidase-dependent pathway / COX-3 is debated). The "COX-3" theory is largely discredited. More accepted: it inhibits COX in the CNS where peroxidase activity is low, and possibly acts via the endocannabinoid system (metabolite AM404), serotonin pathway, and inhibits prostaglandin synthesis in the brain. It's analgesic and antipyretic but NOT meaningfully anti-inflammatory.
|
||||
- Because it doesn't significantly inhibit peripheral COX-1, it doesn't cause the GI bleeding risk of NSAIDs.
|
||||
- Stress organ: liver. Metabolized by CYP450 (CYP2E1, CYP1A2, CYP3A4) to a toxic metabolite NAPQI, normally detoxified by glutathione conjugation. Overdose depletes glutathione → NAPQI accumulates → hepatocellular necrosis. This is the major organ stress — liver.
|
||||
- Kidney: chronic use can cause analgesic nephropathy (rare with normal dosing), and there's some evidence of renal effects with chronic use, but the primary organ is liver.
|
||||
|
||||
**Practical differences:**
|
||||
1. Anti-inflammatory: ibuprofen yes, acetaminophen no. So for joint/injury inflammation (arthritis, sprain, dental), ibuprofen works better.
|
||||
2. Pain relief: both are analgesics; acetaminophen is good for headache, fever, general pain.
|
||||
3. Fever: both antipyretic.
|
||||
4. GI safety: acetaminophen safer for stomach; ibuprofen risks GI bleeding/ulcers, especially in elderly, with steroids, anticoagulants.
|
||||
5. Kidney: ibuprofen risky in CKD, heart failure, dehydration; acetaminophen safer for kidneys (mostly).
|
||||
6. Liver: acetaminophen risky in liver disease, alcohol use, overdose; ibuprofen has less direct hepatotoxicity (though rare).
|
||||
7. Cardiovascular: ibuprofen (NSAIDs) have some CV risk; acetaminophen neutral.
|
||||
8. Drug interactions: ibuprofen interacts with warfarin, aspirin, ACEi/ARBs, diuretics, lithium; acetaminophen fewer interactions (long-term with warfarin can raise INR).
|
||||
9. Dosing: acetaminophen max 3-4g/day (lower if alcohol/liver disease, ~2g); ibuprofen OTC max ~1200mg/day, prescription up to 3200mg/day.
|
||||
10. They can be combined for additive effect.
|
||||
|
||||
Let me be careful about the acetaminophen mechanism — I should present the current consensus honestly: the exact mechanism is still not fully settled, but it's understood to act centrally, inhibiting COX (particularly COX-2) in the CNS, with contributions from the endocannabinoid and serotonergic systems. The COX-3 theory is not widely accepted. I'll note this nuance.
|
||||
|
||||
I have enough to write a thorough, accurate answer. I don't think I need more tool calls. Let me write it well-structured.
|
||||
|
||||
I should include a disclaimer that this is general information, not medical advice, and to consult a clinician, especially with organ disease or other meds.
|
||||
|
||||
Let me structure:
|
||||
- Quick practical summary (the "which when" table)
|
||||
- How ibuprofen works
|
||||
- How acetaminophen works
|
||||
- Organ stress for each
|
||||
- Practical "which to pick" guidance
|
||||
- Safety notes / disclaimer
|
||||
|
||||
Let me write it.
|
||||
|
||||
=== [10] ASSISTANT TEXT ===
|
||||
Both are painkillers and fever-reducers, but they're genuinely different drugs in how they work and where they hurt you. Here's the practical breakdown.
|
||||
|
||||
## The one-line difference
|
||||
- **Ibuprofen** is an NSAID — it reduces inflammation *and* pain, but stresses the **stomach, kidneys, and heart**.
|
||||
- **Acetaminophen (paracetamol)** is an analgesic/antipyretic — it reduces pain and fever but does **not** meaningfully reduce inflammation, and its main risk is to the **liver**.
|
||||
|
||||
## How each one works
|
||||
|
||||
**Ibuprofen (NSAID)**
|
||||
- Blocks the **cyclooxygenase enzymes (COX‑1 and COX‑2)** wherever they're active, cutting down prostaglandin production. Prostaglandins drive inflammation, pain signalling, and fever.
|
||||
- Because it works *at the site of injury/inflammation* as well as in the brain, it's genuinely **anti‑inflammatory** — it reduces swelling, not just the pain you feel.
|
||||
- Side effect: COX‑1 in the stomach lining is "housekeeping" — it makes prostaglandins that protect the gut and keep blood flowing to the kidneys. Blocking it is exactly what causes the GI and renal problems below.
|
||||
|
||||
**Acetaminophen (paracetamol)**
|
||||
- A much **weaker** peripheral COX inhibitor. Its main action is **central** — it suppresses prostaglandin synthesis in the brain/spinal cord (particularly the COX‑2 pathway and related serotonergic/endocannabinoid signalling), which is why it lowers pain and fever.
|
||||
- Because it barely touches peripheral COX‑1, it **doesn't reduce inflammation** and **doesn't irritate the stomach** the way NSAIDs do.
|
||||
- Honest caveat: acetaminophen's exact mechanism is still debated. The old "COX‑3" theory is largely discredited; the current consensus is central COX inhibition plus contributions from other pathways. The practical point (analgesic + antipyretic, not anti‑inflammatory) is solid.
|
||||
|
||||
## Which organs each one stresses
|
||||
|
||||
| | Ibuprofen | Acetaminophen |
|
||||
|---|---|---|
|
||||
| **Stomach/GI** | ⚠️ Main risk — irritation, ulcers, bleeding (esp. with steroids, blood thinners, or age) | Safe — no GI bleeding risk |
|
||||
| **Kidneys** | ⚠️ Main risk — reduces renal blood flow; dangerous in CKD, heart failure, dehydration, or with ACEi/ARBs + diuretics | Generally safe at normal doses |
|
||||
| **Liver** | Low direct risk (rare) | ⚠️ **Main risk** — dose‑dependent toxicity |
|
||||
| **Heart/CV** | ⚠️ Some increased risk (NSAID class effect) | Neutral |
|
||||
|
||||
**Why acetaminophen hits the liver:** it's partly converted by liver enzymes (CYP450) into a toxic metabolite, **NAPQI**, which is normally neutralised by glutathione. In overdose — or with heavy alcohol use / chronic liver disease — glutathione runs out, NAPQI accumulates, and liver cells die. This is the leading cause of acute liver failure in many countries.
|
||||
|
||||
## Practical "which do I pick"
|
||||
- **Inflammation matters** (sprain, arthritis flare, dental pain, back injury): **ibuprofen** works better.
|
||||
- **Headache, fever, general aches, or you have a sensitive stomach / kidney issues / are on blood thinners**: **acetaminophen** is usually the safer first choice.
|
||||
- **Avoid ibuprofen** if you have kidney disease, heart failure, are dehydrated, take ACE inhibitors/ARBs + diuretics, or are at high GI-bleed risk.
|
||||
- **Avoid/limit acetaminophen** if you have liver disease, drink heavily, or take other paracetamol-containing products (many cold/flu meds contain it — the #1 overdose cause is accidental double-dosing).
|
||||
- **Dose caps:** acetaminophen ≤ **3–4 g/day** (lower, ~2 g, with alcohol or liver disease); ibuprofen OTC ≤ **1,200 mg/day** (prescription up to ~3,200 mg/day).
|
||||
- They **can be combined** for additive effect — but count all sources of acetaminophen.
|
||||
|
||||
---
|
||||
⚠️ This is general information, not medical advice. If you have liver or kidney disease, take blood thinners or heart meds, are pregnant, or use alcohol regularly, check with a clinician or pharmacist before choosing — the "safer" drug depends on your specific situation.
|
||||
|
||||
Want me to work through a specific scenario (e.g., "I have X condition and take Y") to reason out which is safer?
|
||||
|
||||
=== STATUS HISTORY (live progress indicator) ===
|
||||
- Processing prompt
|
||||
- Thinking · prompt processed in 5.3 s
|
||||
- Thought: The user is asking about the practical differences between ibuprofen and acetaminophen. This is a medical/pharmacology question. Let me think about what I know…
|
||||
- Calling web_search
|
||||
- Calling web_search
|
||||
- Thinking
|
||||
- Thought: Let me look at the most relevant result — the tandfonline overview of analgesics. Let me fetch that one to confirm the mechanism details.
|
||||
- Calling fetch_page
|
||||
- Thinking
|
||||
- Thought: The paywall blocked it. That's fine — I have strong knowledge of this topic and the search snippets confirm the key points. Let me not over-rely on fetching;…
|
||||
- Writing response
|
||||
- Done · 3 tool calls
|
||||
Reference in New Issue
Block a user